联系客服

300878 深市 维康药业


首页 公告 维康药业:2022年度财务决算报告

维康药业:2022年度财务决算报告

公告日期:2023-04-28

维康药业:2022年度财务决算报告 PDF查看PDF原文

                        浙江维康药业股份有限公司

                        2022年度财务决算报告

          一、2022年度财务报表审计情况

          2022年度财务报表经天健会计师事务所(特殊普通合伙)审计,出具了标准

      无保留意见的审计报告(天健审〔2023〕5788号),天健会计师事务所认为公司

      的财务报表已经按照企业会计准则以及有关规定编制,在所有重大方面公允地反

      映了公司2022年12月31日的财务状况以及2022年度经营成果和现金流量。

          二、经营利润情况

                                                                        单位:人民币元

            项 目              2022年度    2021年度    增减幅          大额变动原因说明

                                                          度

          营业总收入            531,291,689.13  632,953,240.27  -16.06%

            营业成本              220,097,404.87  204,376,208.82    7.69%

          税金及附加              1,852,820.57    4,795,258.15    -61.36%  主要系本期销售收入减少所致

            销售费用              191,642,999.29  269,988,691.21  -29.02%

            管理费用              37,355,321.68  24,749,342.08    50.93%  主要系募投项目的研发中心和仓储中心2幢
                                                                          大楼转固,导致折旧费增加所致

            研发费用              39,320,428.40  37,015,323.92    6.23%

            财务费用              3,325,483.22  -3,031,783.87    209.69%  主要系银行借款增加所致

            其他收益              19,805,355.25  12,246,591.55    61.72%  主要系收到政府补助及递延收益摊销增加
                                                                          所致

            投资收益              10,047,818.03    264,330.53    3701.23%  主要系融资性贸易业务投资收益增长所致

          信用减值损失            -7,242,071.56  -8,408,887.53    -13.88%

          资产减值损失              -221,444.13    -87772.83    152.29%

          资产处置收益              -634,517.94    67,578.16    -1038.94%

            营业利润              59,452,370.75  99,142,039.84    -40.03%


          营业外收入              412,292.22    1,029,712.51    -59.96%

          营业外支出              2,113,710.62    143,691.62    1371.00%  主要系本期对外捐赠增加所致

            利润总额              57,750,952.35  100,028,060.73  -42.27%

          所得税费用              12,630,576.03  3,480,914.78    262.85%  主要系本期可抵扣暂时性差异较上期减

                                                                          少,本期递延所得税增加所致

            净利润                45,120,376.32  96,547,145.95    -53.27%

    归属于母公司股东的净利润      44,444,260.14  96,495,377.13    -53.94%

          少数股东损益              676,116.18      51,768.82    1206.03%

            每股收益                  0.31          0.67      -53.94%

          三、资产负债情况

                                                                        单位:人民币元

    项 目          2022年12月31日      2021年12月31日    增减幅度        大额变动原因说明

    货币资金              162,740,657.58        280,795,523.15        -42.04%  主要系本期大健康产业园项目持
                                                                                  续投入所致

    应收账款                275,185,566.29          373,660,578.13        -26.35%

  应收款项融资              62,262,632.21          36,235,827.05        71.83%  主要系收到银行承兑汇票增加所
                                                                                  致

    预付款项                31,494,504.58          37,455,419.71        -15.91%

  其他应收款              226,923,733.62            2,755,294.65      8135.92%  主要系本期融资性贸易应收款增
                                                                                  加所致

      存货                  116,110,625.18          129,492,497.74        -10.33%

  其他流动资产              24,598,316.03            9,690,787.23      153.83%  主要系本期待抵扣增值税进项税
                                                                                  以及预缴企业所得税增加所致

  流动资产合计              899,316,035.49          870,085,927.66        3.36%

 其他非流动金融资            25,000,000.00          19,964,000.00        25.23%

      产

  投资性房地产                5,571,255.86            5,710,751.66        -2.44%

                                                                                  主要系大健康产业园一期项目房
    固定资产                540,246,937.27          301,928,929.86        78.93%  屋建筑物达到预定可使用状态转
                                                                                  固所致

    在建工程                323,091,620.70          366,565,426.53        -11.86%


    使用权资产              32,185,911.36          37,600,444.05        -14.40%

    无形资产                37,561,885.61          39,305,804.82        -4.44%

      商誉                  27,222,129.15          17,620,063.84        54.50%  主要系本期溢价收购子公司所致

  长期待摊费用                6,106,521.29            7,026,795.23        -13.10%

 递延所得税资产              16,521,330.69          24,594,494.01        -32.83%

 其他非流动资产                949,500.00            2,905,200.00        -67.32%

 非流动资产合计          1,014,457,091.93          823,221,910.00        23.23%

    资产总计              1,913,773,127.42        1,693,307,837.66        13.02%

    短期借款                257,247,305.55          50,060,273.97      413.88%  主要系本期银行借款增加所致

    应付票据                11,020,476.53            6,467,147.69        70.41%  主要系子公司使用银行承兑汇票
                                                                                  支付货款增加所致

    应付账款                84,731,
[点击查看PDF原文]